News
Microbiotica unveils multiple mechanisms by which MB310, in clinical development for the treatment of ulcerative colitis, protects the intestinal barrierData presented at Digestive Disease Week in San ...
Discover a study that has revealed a new potential mechanism of understanding inflammation in ulcerative colitis.
Crohn's disease and ulcerative colitis are idiopathic, chronic, relapsing, inflammatory conditions that are immunologically mediated. Although their exact etiologies remain uncertain, results from ...
OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on ...
A RECENT study has explored the complex relationship between smoking and ulcerative colitis (UC), shedding light on how ...
In type 1 diabetes, the body’s own immune system turns against the pancreas. Cells meant to protect you start destroying ...
Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2025.
The mechanism of action of ABX464 is triggered ... for induction treatment of moderate-to-severe ulcerative colitis (UC), with patients who failed on immunomodulators, anti-TNFα, vedolizumab ...
CAMBRIDGE, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (Seres or the Company), a leading ...
Equillium, Inc. , a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today ...
New Understanding of the Gut Immune System May Hold Promise for Crohn's Disease Patients Mar. 15, 2024 — Scientists uncovered an overlooked mechanism ... Protects Against Colitis in Inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results